tariquidar has been researched along with (2-(4-methoxyphenyl)-4-quinolinyl)(2-piperidinyl)methanol in 1 studies
| Studies (tariquidar) | Trials (tariquidar) | Recent Studies (post-2010) (tariquidar) | Studies ((2-(4-methoxyphenyl)-4-quinolinyl)(2-piperidinyl)methanol) | Trials ((2-(4-methoxyphenyl)-4-quinolinyl)(2-piperidinyl)methanol) | Recent Studies (post-2010) ((2-(4-methoxyphenyl)-4-quinolinyl)(2-piperidinyl)methanol) |
|---|---|---|---|---|---|
| 210 | 16 | 138 | 11 | 0 | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arabzadeh, S; Behravan, J; Hadizadeh, F; Mollazadeh, S; Sahebkar, A | 1 |
1 review(s) available for tariquidar and (2-(4-methoxyphenyl)-4-quinolinyl)(2-piperidinyl)methanol
| Article | Year |
|---|---|
Structural and functional aspects of P-glycoprotein and its inhibitors.
Topics: Acridines; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Biological Products; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Lipid Bilayers; Molecular Targeted Therapy; Piperidines; Protein Conformation; Quinolines; Tetrahydroisoquinolines | 2018 |